Home > Insider Trading > Filing (0001209191-14-075863)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1008848	Acorda Therapeutics Inc	ACOR	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1176268	Phd Sandra Panem	420 Saw Mill River Road Ardsley NY 10502		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-12-12	10,000	$31.61	12,912	No	4	M	Direct
Common Stock	Disposition	2014-12-12	10,000	$38.10	2,912	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Employee Stock Option	Disposition	2014-12-12	10,000	$0.00	10,000	$31.61

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-06-09	No	4	M	Direct

Footnotes

Pursuant to a contractual arrangement between the reporting person and Cross Atlantic Partners, Inc., the reporting person disclaims beneficial ownership of these stock options and the corresponding 10,000 shares in the aggregate that were issued from the exercise of these options and were sold by the reporting person as reported on this form.
The shares subject to this option vested in four equal quarterly installments over 12 months beginning June 9, 2010, with the first quarter fully vesting on September 9, 2010.